Literature DB >> 10514098

Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis.

A Oturai1, F Larsen, L P Ryder, H O Madsen, J Hillert, S Fredrikson, M Sandberg-Wollheim, M Laaksonen, N Koch-Henriksen, S Sawcer, L Fugger, P S Sorensen, A Svejgaard.   

Abstract

In the genetically homogeneous Scandinavian population, we have investigated chromosome 5 and the HLA (human leukocyte antigen) region on chromosome 6p21 by applying linkage and association analyses on 106 white sibling pair families with multiple sclerosis. The importance of genes within the HLA region for the susceptibility of multiple sclerosis has previously been reported. More recently, findings have suggested importance of regions on chromosome 5. Half of chromosome 5 was analyzed by using 14 microsatellite markers and a susceptibility region with a maximum LOD score of 1.1 was identified. Chromosome 6 was analyzed by HLA-DR typing and using the TNF alpha microsatellite marker. A peak maximum LOD score of 2.0 was found at the HLA-DR marker. Association studies were made for all the markers, comparing 106 probands from the sibling pairs with 100 unrelated controls. None of the markers on chromosome 5 showed significant association with multiple sclerosis, whereas strong association between multiple sclerosis and DR2 was found, with an odds ratio of 3.7 (p < 10(-5)). It is surprising that association was not seen for any of the TNF alpha alleles including the 121-bp allele, although this allele was in positive linkage disequilibrium with DR2 in both patients and controls. Our results support the existence of multiple sclerosis susceptibility loci on chromosomes 5p and 6p21.

Entities:  

Mesh:

Year:  1999        PMID: 10514098

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive.

Authors:  Maartje Boon; Ilja M Nolte; Jacques De Keyser; Charles H C M Buys; Gerard J te Meerman
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

2.  A genomewide scan for type 1-diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions.

Authors:  J Nerup; F Pociot
Journal:  Am J Hum Genet       Date:  2001-10-11       Impact factor: 11.025

3.  Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids.

Authors:  A E Leonard; E G Bobik; J Dorado; P E Kroeger; L T Chuang; J M Thurmond; J M Parker-Barnes; T Das; Y S Huang; P Mukerji
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

4.  Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population.

Authors:  Bao-Ying Fei; Bing Xia; Chang-Sheng Deng; Xiao-Qing Xia; Min Xie; J Bart A Crusius; A Salvador Pena
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

5.  HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Authors:  Michael J Chao; Martin C N M Barnardo; Matthew R Lincoln; Sreeram V Ramagopalan; Blanca M Herrera; David A Dyment; Alexandre Montpetit; A Dessa Sadovnick; Julian C Knight; George C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

6.  A genome-wide scan in forty large pedigrees with multiple sclerosis.

Authors:  Cristen J Willer; David A Dyment; Stacey Cherny; Sreeram V Ramagopalan; Blanca M Herrera; Katie M E Morrison; A Dessa Sadovnick; Neil J Risch; George C Ebers
Journal:  J Hum Genet       Date:  2007-11-15       Impact factor: 3.172

7.  Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.

Authors:  Suvi P Kallio; Eveliina Jakkula; Shaun Purcell; Minna Suvela; Keijo Koivisto; Pentti J Tienari; Irina Elovaara; Tuula Pirttilä; Mauri Reunanen; Denis Bronnikov; Markku Viander; Seppo Meri; Jan Hillert; Frida Lundmark; Hanne F Harbo; Aslaug R Lorentzen; Philip L De Jager; Mark J Daly; David A Hafler; Aarno Palotie; Leena Peltonen; Janna Saarela
Journal:  Hum Mol Genet       Date:  2009-02-16       Impact factor: 6.150

Review 8.  The immunogenetics of multiple sclerosis.

Authors:  Arne Svejgaard
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

9.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15

Review 10.  A mitochondrial component of neurodegeneration in multiple sclerosis.

Authors:  Bernadette Kalman; Thomas P Leist
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.